tradingkey.logo

BRIEF-Conduit Pharmaceuticals Partners With Charles River In Systemic Lupus Erythematosus Model

ReutersFeb 13, 2025 1:07 PM

- Conduit Pharmaceuticals CDT.O:

  • CONDUIT PHARMACEUTICALS INC: PARTNERS WITH CHARLES RIVER IN CLINICALLY RELEVANT SYSTEMIC LUPUS ERYTHEMATOSUS MODEL

  • CONDUIT PHARMACEUTICALS: STUDY TO ACCELERATE DEVELOPMENT OF AZD1656 FOR AUTOIMMUNE DISORDERS, FOCUS ON SYSTEMIC LUPUS ERYTHEMATOSUS, LUPUS NEPHRITIS

Source text: ID:nGNX6dgWCT

Further company coverage: CDT.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI